248 related articles for article (PubMed ID: 12020257)
1. Demyelinating neuropathy in diabetes mellitus.
Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
Lotan I; Hellman MA; Steiner I
Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
[TBL] [Abstract][Full Text] [Related]
3. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy.
Sharma KR; Cross J; Ayyar DR; Martinez-Arizala A; Bradley WG
Arch Neurol; 2002 May; 59(5):751-7. PubMed ID: 12020256
[TBL] [Abstract][Full Text] [Related]
4. [The clinical analysis of diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy].
Sun QL; Sun AP; Fu Y; Fan DS
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):749-752. PubMed ID: 30293336
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prevalence of CIDP and the association of diabetes mellitus.
Laughlin RS; Dyck PJ; Melton LJ; Leibson C; Ransom J; Dyck PJ
Neurology; 2009 Jul; 73(1):39-45. PubMed ID: 19564582
[TBL] [Abstract][Full Text] [Related]
6. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
7. Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy.
Fleischer M; Lee I; Erdlenbruch F; Hinrichs L; Petropoulos IN; Malik RA; Hartung HP; Kieseier BC; Kleinschnitz C; Stettner M
J Neuroinflammation; 2021 Apr; 18(1):89. PubMed ID: 33832507
[TBL] [Abstract][Full Text] [Related]
8. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
[TBL] [Abstract][Full Text] [Related]
9. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
Bril V; Blanchette CM; Noone JM; Runken MC; Gelinas D; Russell JW
J Diabetes Complications; 2016; 30(7):1401-7. PubMed ID: 27389526
[TBL] [Abstract][Full Text] [Related]
10. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
Jann S; Bramerio MA; Facchetti D; Sterzi R
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
13. Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
Abraham A; Breiner A; Katzberg HD; Lovblom LE; Perkins BA; Bril V
Expert Rev Clin Immunol; 2015 Apr; 11(4):537-46. PubMed ID: 25764107
[TBL] [Abstract][Full Text] [Related]
14. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.
Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA
Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of chronic inflammatory demyelinating polyneuropathy.
Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
[TBL] [Abstract][Full Text] [Related]
16. Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy.
Gorson KC; Ropper AH; Adelman LS; Weinberg DH
Muscle Nerve; 2000 Jan; 23(1):37-43. PubMed ID: 10590404
[TBL] [Abstract][Full Text] [Related]
17. Research criteria for defining patients with CIDP.
Sander HW; Latov N
Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP.
Jann S; Bramerio MA; Beretta S; Koch S; Defanti CA; Toyka KV; Sommer C
Neurology; 2003 Dec; 61(11):1607-10. PubMed ID: 14663052
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
[TBL] [Abstract][Full Text] [Related]
20. [A case of CIDP with diabetes mellitus who had good response to intravenous immune globulin].
Nakano M; Takase Y; Tatsumi C; Miura A; Matsuyama T; Kadekawa J; Yoshikawa H
Rinsho Shinkeigaku; 2002 Jan; 42(1):32-4. PubMed ID: 12355849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
